WallStreetZenWallStreetZen

NASDAQ: NIVF
Newgenivf Group Ltd Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Newgenivf Group earnings were $130.2k for the trailing 12 months ending Dec 31, 2023, with -77.5% growth year over year. The latest NIVF earnings report on Dec 31, 2023 announced Q4 2023 earnings of -$134.4k, down 205.8% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, NIVF reported annual earnings of $130.2k, with -71.6% growth.

NIVF past earnings growth

How has NIVF's earnings growth performed historically?

Company
-77.5%
Industry
87.65%
Market
50.24%
NIVF's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
NIVF's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

NIVF earnings history

Current Revenue
$5.1M
Current Earnings
$130.2k
Current Profit Margin
2.5%

NIVF Return on Equity

Current Company
-8.6%
Current Industry
-82.7%
Current Market
31.3%
NIVF's Return on Equity (-3.1%)... subscribe to Premium to read more.
High Return on Equity Performance

NIVF Return on Assets

Current Company
0.6%
Current Industry
5.7%
NIVF is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when NIVF announces earnings.

NIVF Return on Capital Employed

Current Company
33.59%
Current Industry
11.9%

NIVF vs Medical Care Facility Stocks

TickerEBITDAEarningsY/Y EarningsEPS
NIVF$406.08k$130.19k-77.50%$0.18
SYRA-$4.19M-$4.25MN/A-$0.65
RHE$1.83M-$2.89MN/A-$1.55
BACK-$5.75M-$6.13MN/A-$5.37
TOI-$44.11M-$55.04MN/A-$0.78
View Top Medical Care Facility Stocks

Newgenivf Group Earnings Reports & History FAQ

What were Newgenivf Group's earnings last quarter?

Newgenivf Group (NASDAQ: NIVF) reported Q4 2023 earnings per share (EPS) of $1.08, up 38.29% year over year. Total NIVF earnings for the quarter were -$134.45 thousand. In the same quarter last year, Newgenivf Group's earnings per share (EPS) was $1.75.

If you're new to stock investing, here's how to buy Newgenivf Group stock.

Is Newgenivf Group profitable or losing money?

As of the last Newgenivf Group earnings report, Newgenivf Group is currently profitable. Newgenivf Group's net profit (also called net income) for the twelve months ending Dec 31, 2023 was $130.19 thousand, a 71.61% decrease year over year.

What was NIVF's earnings growth in the past year?

As of Newgenivf Group's earnings date in Q4 2024, Newgenivf Group's earnings has grown -77.5% year over year. This is 165.15 percentage points lower than the US Medical Care Facilities industry earnings growth rate of 87.65%. NIVF earnings in the past year totalled $130.19 thousand.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.